Annual cost of lymphedema treatment fell $12,000, study found
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Preliminary research suggests it might be safe to shorten the current 3-year treatment
Sat Feb 16, 2013 08:54 PM
Well, you are talking about side effects of hormone treatment (physical quality of life), but how patient has to feel himself, when doctor tells him, how many years left to live? Counts how many times he might go on vacation, change his lifestyle (does not make common sense to continue), etc. How he should feel, when he has deadline, literally. Do you think, that will be merciful to do not tell patients that information? Just treat them. It is the worst thing, when people lose the hope. Am I right?
We care about your feedback. Let us know how we can improve your CancerCompass experience.